Global Dental Bone Graft Substitutes and Regenerative Materials Pipeline Landscape Market Report 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Dental Bone Graft Substitutes and Regenerative Materials – Medical Devices Pipeline Product Landscape, 2021” report has been added to ResearchAndMarkets.com’s offering.

“Dental Bone Graft Substitutes & Regenerative Materials – Medical Devices Pipeline Product Landscape, 2021′ provides comprehensive information about the Dental Bone Graft Substitutes & Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease or developmental deficiency.

Scope

• Extensive coverage of the Dental Bone Graft Substitutes & Regenerative Materials under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Dental Bone Graft Substitutes & Regenerative Materials and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Dental Bone Graft Substitutes & Regenerative Materials under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Dental Bone Graft Substitutes & Regenerative Materials Overview

3 Products under Development

3.1 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development

3.2 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Segment

3.3 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Territory

3.4 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Regulatory Path

3.5 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Estimated Approval Date

3.6 Dental Bone Graft Substitutes & Regenerative Materials – Ongoing Clinical Trials

4 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products under Development by Companies

4.1 Dental Bone Graft Substitutes & Regenerative Materials Companies – Pipeline Products by Stage of Development

4.2 Dental Bone Graft Substitutes & Regenerative Materials – Pipeline Products by Stage of Development

5 Dental Bone Graft Substitutes & Regenerative Materials Companies and Product Overview

5.1 3-D Matrix Ltd Company Overview

5.2 CellSeed Inc Company Overview

5.3 Collagen Matrix Inc Company Overview

5.4 Colorado Therapeutics, LLC Company Overview

5.5 CoreBone Ltd. Company Overview

5.6 credentis AG Company Overview

5.7 curasan AG Company Overview

5.8 Fujifilm Corp Company Overview

5.9 Histocell SL Company Overview

5.10 Indian Institute of Technology Bombay Company Overview

5.11 Induce Biologics Inc. Company Overview

5.12 Malla Reddy Institute of Medical Sciences Company Overview

5.13 Maxigen Biotech Inc Company Overview

5.14 Medtronic Plc Company Overview

5.15 Nobel Biocare Services AG Company Overview

5.16 Novatissue SAS Company Overview

5.17 Orthocell Ltd Company Overview

5.18 Orthogen LLC Company Overview

5.19 Orthorebirth Co Ltd Company Overview

5.20 Orthosera GmbH Company Overview

5.21 PolyPid Ltd Company Overview

5.22 Polytechnic University of Catalonia Company Overview

5.23 RevBio Inc Company Overview

5.24 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.25 Straumann Holding AG Company Overview

5.26 SurgaColl Technologies Ltd Company Overview

5.27 SweetBio, Inc. Company Overview

5.28 Tetratherix Pty Ltd Company Overview

5.29 Tigran Technologies AB Company Overview

5.30 University of Bielefeld Company Overview

5.31 University of Maryland Company Overview

6 Dental Bone Graft Substitutes & Regenerative Materials- Recent Developments

6.1 Nov 18, 2021: Zimmer Biomet to Present at Evercore ISI’s 4th Annual HealthCONx Conference

6.2 Nov 18, 2021: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results

6.3 Nov 03, 2021: Zimmer Biomet to Present at Stifel’s 2021 Virtual Healthcare Conference

6.4 Oct 18, 2021: Straumann Group 2021 third-quarter financial results webcast invitation

6.5 Sep 23, 2021: Dentsply Sirona announces a comprehensive restage of its implant business

6.6 Aug 19, 2021: CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results

6.7 Aug 03, 2021: Zimmer Biomet Announces Second Quarter 2021 Financial Results

6.8 Jul 29, 2021: Invitation: Straumann Group 2021 half-year financial results webcast

6.9 Jul 27, 2021: Stryker reports second quarter 2021 operating results

6.10 Jul 19, 2021: Leading dental manufacturer, Vista Apex, develops first of its kind bio-regenerative materials

6.11 Jul 15, 2021: Christian Ullrich joins Straumann Group’s Executive Management Board as the new Group Chief Information Officer

6.12 Apr 29, 2021: First-quarter 2021 report Media Release

6.13 Apr 06, 2021: Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2021 Financial Results

6.14 Mar 31, 2021: Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team

6.15 Mar 19, 2021: Zimmer Biomet expands role for Ivan Tornos appointing him to new COO

6.16 Mar 09, 2021: Dentsply Sirona to Present at the 2021 Barclays Global Healthcare Conference on March 10th

6.17 Mar 04, 2021: CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference

6.18 Feb 18, 2021: Zimmer Biomet to Present at the Cowen 41st Annual Health Care Conference

6.19 Feb 17, 2021: Stryker to participate in the 41st Annual Cowen Health Care Conference

6.20 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences

6.21 Feb 16, 2021: Vafa Jamali Appointed as CEO of NewCo , New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet

6.22 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

6.23 Feb 10, 2021: Zimmer Biomet to Present at Citi’s 2021 Healthcare Services, Medtech, Tools, and HCIT Virtual Conference

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/l96zoi

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900